Half-year report · Q2
7129.TEDINET S100UOS3
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.5bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥22.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥125m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥25m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥120m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥374m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥168m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥40m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥112m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥33m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥13.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥13.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.7bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.5bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.3bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥174m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥810m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥217m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥336m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥144m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥425m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥610m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥621m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥43.61 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.21 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.06 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥43.14 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥2.2 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 26.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.2% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥468m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥444m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥493m |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥364m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.7bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥266m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥22m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥24m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥618m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥452m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥431m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥22m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥462m |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E36714-000Childcaresupport Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥323m |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E36714-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥243m |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E36714-000Nursing Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥86m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥10.6bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥481m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥22m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥487m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 562
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about assets for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about assets for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |